For Research Purposes Only — This compound is not FDA approved.

Catalog
KPV
Anti-Inflammatory Research

KPV

A tripeptide fragment of alpha-MSH studied for inflammatory-pathway signaling in research models. Premium Research Peptide.

Amount
Quantity
1
Bundle & Save
COA
Only 42 left in stock 18 people viewing now
Est. delivery in 2–5 business days
Free shipment protection
Overnight shipping available

Certificate of Analysis

Third Party Tested Janoshik
99.27%
Purity · HPLC-UV
Latest BatchLC-MS IdentityThird-Party Verified
Passed QC panel
Lot KPV10-001Tested Feb 6, 2026
Purity (HPLC-UV)99.27%
Net Peptide Content12.09mg
Identity (LC-MS)KPV
Janoshik · Independent third-party lab View full COA

Compound Information

Technical specifications
Molecular Profile

What is KPV?

TypeSynthetic peptide
CAS Number67727-97-3
Molecular Weight342.43 g/mol
Amino Acids3
Molecular FormulaC16H30N4O4
PubChem Database KPV Research Guide
Storage Requirements

Stability Information

Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
−20°C · 24+ months
Reconstituted
2–8°C · ~30 days

Research Background

For laboratory research use only

What KPV is

KPV is the tripeptide lysine-proline-valine, with a molecular weight of 342.43 g/mol. It corresponds to the last three residues, positions 11 to 13, of alpha-melanocyte-stimulating hormone (alpha-MSH), a 13-amino-acid peptide hormone. Researchers became interested in the fragment when it was reported that this short C-terminal piece retained some of the parent hormone's effects on inflammatory signalling in cell models while lacking its pigmentary activity, which depends on a different part of the sequence.

How the fragment acts is still an open question in the literature. Some studies attribute its effects to melanocortin receptors; others report activity in cells where those receptors are absent and point to uptake by a peptide transporter instead. Anyone designing an experiment around KPV should read both lines of work.

What the preclinical literature has examined

  • NF-kB signalling in cultured cells. In vitro studies in intestinal epithelial cells and immune cells measuring NF-kB activation and the cytokines downstream of it.
  • Transporter-mediated uptake. Work reporting that the tripeptide is a substrate of PepT1, the di- and tripeptide transporter of the intestinal epithelium.
  • Murine colitis models. Studies in chemically induced models of intestinal inflammation in mice, including delivery in nanoparticle formulations.
  • Skin and epithelial cell models. Work in keratinocytes and related cell types following from the alpha-MSH literature.

These are cell and animal findings. KPV is not an approved drug, and this material is supplied for in vitro and laboratory research only, not for human or veterinary use. The KPV research guide covers the literature in more depth.

How this material is characterised

A tripeptide is analytically awkward in ways a larger peptide is not. KPV has no aromatic amino acid, so it does not absorb at the wavelength often used for proteins; HPLC-UV purity for a compound like this relies on the absorbance of the peptide bond itself at short wavelength. It is also small and hydrophilic, which means it is weakly retained on a reversed-phase column. For both reasons LC-MS identity, which confirms the molecular mass directly, is an important complement to the purity figure. Net peptide content matters too: the lysine side chain and the free N-terminus each carry a counter-ion, and in a molecule this small those counter-ions are a meaningful share of the powder mass. All three results are on the Certificate of Analysis above. See HPLC vs mass spectrometry and how to read a Certificate of Analysis.

Handling in the laboratory

KPV is chemically robust. Its three residues include none of those prone to oxidation, and the proline in the middle makes the peptide bond on either side less accessible to many peptidases. The practical concerns are physical: the powder is hygroscopic and the quantities are small. Let the vial reach room temperature before opening, dissolve in aqueous solvent with gentle swirling, and base concentrations on net peptide content, not on label mass. Keep the lyophilised powder frozen and dry, refrigerate solutions, and aliquot a stock into single-use volumes. See peptide storage and stability and how to reconstitute a research peptide.

Common questions

What does KPV stand for?

K, P and V are the one-letter codes for lysine, proline and valine. KPV is the tripeptide Lys-Pro-Val, molecular weight 342.43 g/mol, CAS number 67727-97-3.

How is KPV related to alpha-MSH?

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, corresponding to residues 11 to 13 of that 13-amino-acid hormone. The literature describes it as lacking the pigmentary activity of the full hormone.

Is KPV an approved drug?

No. KPV is not an approved medicine. This material is sold for in vitro and laboratory research only and is not for human or veterinary use.

Why is mass spectrometry important for a tripeptide?

KPV has no aromatic residue and is weakly retained on reversed-phase columns, so UV-based HPLC alone gives limited information. LC-MS confirms the molecular mass directly and is the stronger evidence of identity.

How should lyophilised KPV be stored?

Keep the lyophilised powder at -20 C, dry and protected from light, and let the vial warm to room temperature before opening because the powder is hygroscopic. After reconstitution store at 2-8 C in single-use aliquots.

Frequently Researched Together

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing, you confirm that you are a qualified researcher and will use these products in accordance with all applicable laws and regulations.